Myelin Oligodendrocyte Glycoprotein (MOG) (AA 35-55) Peptide
-
- Target See all MOG products
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
- Protein Region
- AA 35-55
-
Source
- Synthetic
- Supplier Product No.
- 000-001-m41
- Supplier
- Rockland
- Purpose
- Myelin oligodendrocyte glycoprotein (MOG) Peptide
- Purity
- Greater than 95% specific peptide.
-
Myelin Oligodendrocyte Glycoprotein (MOG) peptide
MOG Reactivity: Human, Cow, Mouse, Pig, Rat Host: Synthetic BP, Imm
-
- Application Notes
-
Other: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum per assay.
Application_Note: Myelin oligodendrocyte glycoprotein (MOG) Control Peptide is suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays. Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay. Specific conditions for reactivity should be optimized by the end user.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
-
Reconstitution_Buffer: Restore with deionized water (or equivalent)
Reconstitution_Volume: 1.0 mL
- Concentration
- 1.0 mg/mL
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store vial at 2 - 8 ° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
- Expiry Date
- 12 months
-
- Target
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
- Background
-
Synonyms: Myelin oligodendrocyte glycoprotein, MOG, control peptide, blocking peptide
Background: Myelin oligodendrocyte glycoprotein (MOG) is a minor constituent of the CNS myelin synthesized by oligodendrocytes and Schwann cells and is thought to mediate homophilic cell-cell adhesion among other roles. MOG, Myelin basic protein (MBP), and proteolipid proteins (PLP) are potential primary encephalitogenic target antigens in multiple sclerosis.
-
